Home | Welcome to Contract Pharma   
Last Updated Friday, October 31 2014
Print RSS Feed

Breaking News

Related Searches:
May 4, 2010
Singulair sales were $1.2 billion (+10%). Remicade sales were $674 million (+30%).   Read More »
May 4, 2010
Vetter, a provider of aseptic pre-filled drug-delivery systems, and Sentry BioPharma Services, a provider of supply chain management and clinical packaging services, have signed a preferred partnership agreement.   Read More »
May 4, 2010
Douglas M. Fast, Ph.D. has joined Covance as scientific director Bioanalytical Services.   Read More »
May 3, 2010
Althea Technologies, Inc. has acquired the assets and portfolio of Altus Pharmaceuticals.   Read More »
May 3, 2010
DSM Biologics has entered an agreement to partner with the Australian Governments (Queensland State Government and the Commonwealth of Australia) to design, build and operate a mammalian biopharmaceutical manufacturing facility in Brisbane.  Read More »
May 3, 2010
AstraZeneca and Pozen, Inc. received approval from the FDA for Vimovo (naproxen and esomeprazole magnesium) delayed-release tablets for the relief of symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of  Read More »
May 3, 2010
Dr. John Ellingboe has been appointed senior vice president of Discovery Chemistry for GVK Biosciences.   Read More »
April 30, 2010
Dendreon Corp. received approval from the FDA for Provenge (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC).  Read More »
April 30, 2010
Specialty pharmaceutical sales increased 10% to $907.3 million in the quarter.   Read More »
April 30, 2010
Celgene Corp. has made senior management changes. Dr. Sol J. Barer currently chief executive officer, will serve as executive chairman of the board of directors through December 31, 2010, and Robert J. Hugin, currently president and chief operating office  Read More »
April 29, 2010
U.S. and International sales increased 11% to $3.1 billion and $1.7 billion, respectively.   Read More »
April 29, 2010
Merck has made several senior management changes. Richard T. Clark, currently chairman, chief executive officer and president, will continue leading the company.   Read More »
April 29, 2010
Early development revenues were $205.0 million (+7%).  Read More »
April 29, 2010
Goodwin Biotechnology Inc., a full service contract biomanufacturing company, and Hyprocell LLC, a provider of clinical cell line development services, have entered into a collaboration agreement to create a business model enabling customers to access the  Read More »
April 28, 2010
Norwich Pharmaceuticals, Inc. has formed Norwich Clinical Services to provide clinical testing capabilities to expand the company’s third party services.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On